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http://dx.doi.org/10.1016/j.stemcr.2016.09.013SUMMARYPro-neural transcription factors and small molecules can induce the reprogramming of fibroblasts into functional neurons; however, the
immediate-early molecular events that catalyze this conversion have not been well defined. We previously demonstrated that neuroge-
nin 2 (NEUROG2), forskolin (F), and dorsomorphin (D) can reprogram fibroblasts into functional neurons with high efficiency. Here,
we used this model to define the genetic and epigenetic events that initiate an acquisition of neuronal identity. We demonstrate that
NEUROG2 is a pioneer factor, FD enhances chromatin accessibility and H3K27 acetylation, and synergistic transcription activated by
these factors is essential to successful reprogramming. CREB1 promotes neuron survival and acts with NEUROG2 to upregulate SOX4,
which co-activates NEUROD1 and NEUROD4. In addition, SOX4 targets SWI/SNF subunits and SOX4 knockdown results in extensive
loss of open chromatin and abolishes reprogramming. Applying these insights, adult human glioblastoma cell and skin fibroblast reprog-
ramming can be improved using SOX4 or chromatin-modifying chemicals.INTRODUCTION
Fibroblast-to-neuron reprogramming has been demon-
strated using transcription factors (Vierbuchen et al.,
2010; Pang et al., 2011) and signaling molecules (Hu
et al., 2015; Li et al., 2015). These factors jump-start tran-
scriptional programs that redefine cellular identity; how-
ever, the potency of each reprogramming factor is cell age
and lineage dependent (Liu et al., 2013; Masserdotti et al.,
2015; Mertens et al., 2015). Therefore, mechanistically,
the success of neuronal reprogramming depends upon
the cell-of-origin genetic and epigenetic environment,
as well as the ability of reprogramming factors to navi-
gate that environment and induce reprogramming. For
instance, the pioneer activity of ASCL1 and the permissible
chromatin structures of mouse embryonic fibroblasts facil-
itate rapid neuronal reprogramming (Wapinski et al.,
2013). Likewise, direct competition for pro-neural genetic
elements between endogenous repressor complexes and
overexpressed neurogenin 2 (NEUROG2) regulates reprog-
ramming of mouse astroglia in short versus prolonged cul-
ture (Masserdotti et al., 2015).
NEUROG2 is a basic helix-loop-helix transcription factor
that promotes early neurogenesis (Ma et al., 1996; Fode
et al., 1998; Scardigli et al., 2001). NEUROG2 overexpres-
sion in mouse embryonic stem cells and cultured mouse
cortical astroglia catalyzes conversion into functional,
synapse-forming glutamatergic neurons (Berninger et al.,
2007; Heinrich et al., 2010; Thoma et al., 2012). While
NEUROG2 is sufficient to induce reprogramming in neural
lineage cells, this factor is unable to independently repro-
gram somatic fibroblasts (Liu et al., 2013; Chanda et al.,Stem Cell R
This is an open access article under the C2014). The high-efficiency reprogramming of human fetal
fibroblasts (MRC-5) into functional cholinergic neurons by
NEUROG2 requires simultaneous exposure to the small
molecules forskolin, a cyclic AMP (cAMP) synthesis acti-
vator, and dorsomorphin, an inhibitor of AMP-activated
protein kinase and bone morphogenetic protein type 1 re-
ceptors (Liu et al., 2013). Furthermore, the inclusion of
SOX11 is required to rapidly convert adult human skin
fibroblasts into neurons (Liu et al., 2013). These findings
demonstrate that age- and lineage-specific genetic and
epigenetic factors directly affect the ability of NEUROG2
to catalyze reprogramming.
Here, we perform a systematic analysis of the individual
and synergistic actions of NEUROG2 and small molecules
during reprogramming. We define critical genetic interac-
tions, hierarchical transcription programs, epigenetic his-
tone signatures, and open chromatin conformations that
drive the immediate-early stage of reprogramming, then
apply these discoveries to adult human skin and glioblas-
toma cells refractory to reprogramming.RESULTS
SmallMolecules SynergizewithNEUROG2 to Enhance
Chromatin Occupancy and Redefine the
Transcriptional Profile of Fibroblasts
MRC-5 fibroblasts transduced with NEUROG2-encoding
lentivirus exhibit limited capacity for neuronal reprogram-
ming; however, exposure to forskolin and dorsomorphin
(FD) triggers adoption of class III b-tubulin (TUBB3)+
and microtubule-associated protein 2 (MAP2)+ neuronaleports j Vol. 7 j 955–969 j November 8, 2016 j ª 2016 The Authors. 955
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Small Molecules Enhance
NEUROG2 Chromatin Occupancy and
Activate Synergistic Transcription
(A) Stepwise timeline for fibroblast-to-
neuron reprogramming with ATAC-seq,
ChIP, ChIP-seq, and RNA-seq experiments
annotated. DPI, days post infection; DPT,
days post treatment with FD.
(B) Diagram representing the effects of FD
exposure on NEUROG2 peak score for bind-
ing events detected at 0.5, 1, and 2 DPT. The
change in peak intensity is represented as a
ratio of the peak score in the presence
versus absence of FD with the Venn diagram
depicting the number of NFD-unique events
at 0.5, 1, and 2 DPT (biological replicates,
n = 3 for each time point and condition).
(C) Hierarchical clustering and heatmap
of changes in transcription detected by
RNA-seq relative to control fibroblasts.
FD, fibroblasts exposed to FD; N, NEUROG2-
transduced fibroblasts; NFD, NEUROG2-
transduced fibroblasts exposed to FD (bio-
logical replicates, n = 3 for each time point
and condition).
(D) Pie diagrams representing the respec-
tive number of genes induced by NEUROG2,
FD, and NEUROG2-FD synergistic action at 2
DPT. Synergy represents genes only induced
in the NFD condition.
(E) Time-course representation of the
change in transcript expression intensity
for genes regulated by FD, NEUROG2, or
NFD synergy.
(F) Sunburst diagram depicting the upre-
gulated and downregulated genes at each
time point, the intensity of expression
change at 2 DPT, and corresponding
NEUROG2 ChIP-seq annotation data. Each
segment represents one collection of time
points. For example, the section with
pink, red, and deep-red segments represents
genes with significant differential expression at all time points, while the section with only a pink segment represents genes differentially
expressed only at 0.5 DPT. The gray outer gradient represents the expression change observed for the genes in each section. NEUROG2
binding events are annotated with a blue line segment.identity with greater than 90% efficiency in 14 days
(Liu et al., 2013). To investigate the genetic mechanisms
that catalyze reprogramming, we performed chromatin
immunoprecipitation-sequencing (ChIP-seq) and RNA-
sequencing (RNA-seq) analyses at 0.5, 1, and 2 days post
FD treatment (DPT) (Figure 1A).
A ChIP-seq time-course analysis was performed to
define the ordered genomic targets of NEUROG2 and
identify whether FD significantly modify occupancy at
these sites. NEUROG2 was immunoprecipitated from
MRC-5 in both the absence and presence of FD at 0.5,956 Stem Cell Reports j Vol. 7 j 955–969 j November 8, 20161, and 2 DPT. Replicates exhibited strong enrichment of
pro-neural genetic targets, as well as the enhancer box
motif (50-CANNTG-30). A condition-dependent compari-
son of NEUROG2 occupancy profiles revealed that FD
both enhance NEUROG2 binding intensity at shared sites
and induce binding at novel targets undetected in the
absence of FD (Figure 1B). NEUROG2 was detected at up
to 4-fold higher levels for both time-stable and dynamic
binding events following FD treatment, indicating that
FD affect NEUROG2 chromatin affinity or accessibility
(Figure S1A).
The distribution of NEUROG2-bound sites is biased
toward intergenic and intronic regions (Figure S1B).
Although FD modestly enhanced promoter and transcrip-
tion start site (TSS) occupancy, NEUROG2 seems to domi-
nantly regulate transcription via distal regulatory elements.
To define how occupancy at primary and FD-enhanced
sites affects the transcription, we isolated RNA from FD-
treated, NEUROG2-transduced, and NEUROG2-transduced
FD-treated (NFD) fibroblasts at 0.5, 1, and 2 DPT. Sequence
reads were normalized to time-point-specific GFP-trans-
ducedMRC-5 for differential expression analysis (Table S1).
NEUROG2 immediately induced an upward shift in the
expression of neural genes such as DLL3 and HES6. While
FD independently activated relatively few neural-specific
genes, these small molecules did significantly upregulate
a small subset of diverse genes including C6ORF176,
C11ORF96, DNER, NR4A1, NR4A2, NRG1, and PPARGC1A
(Figure 1C). In combination with NEUROG2, FD induced
the expression of hundreds of genes unaltered by individ-
ual factors (Figure 1D). A temporal analysis of gene expres-
sion underscores the rapid rate of change induced by NFD
(Figure 1E). Synergistic regulation accounted for 53%of the
total change in gene expression at 2DPTand the total num-
ber of genes exhibitingR5-fold change increased from 4%
to 10% within the 36-hr window from 0.5 to 2 DPT.
The synergistic induction of NEUROD1, NEUROD4, and
SOX4, as well as ontological classification of immediately
repressed and early-induced gene sets, highlight the func-
tional significance of these targets (Figure S2A). Further-
more, upregulation of the basal forebrain markers NTRK1
and SSTR2 as well as the cholinergic receptor CHRNA3
and vesicular transporter SLC18A3 suggests that these
early neurons are initially biased toward a cholinergic fate
(Figure S2B).
To define how NEUROG2 binding correlates to the
changes detected by RNA-seq, we used proximity-
based peak-to-gene annotation to identify differentially
expressed genes targeted by NEUROG2 (Figure 1F). These
results revealed direct overlap between ChIP-seq and
RNA-seq datasets ranging from high-level pan-neuronal
genes to single genes such asDLL3 and SOX4. This analysis
demonstrates that NEUROG2 is the primary activator
of pro-neural gene expression, and FD complement this
neurogenic program by enhancing transcription in a
NEUROG2-sensitive manner.
Small Molecules Induce Genome-wide Chromatin
Remodeling
The relative accessibility of genetic elements is cell lineage
dependent and directly regulates the reprogramming
potency of transcription factors. To define the binding
properties of NEUROG2 in MRC-5 fibroblasts, we used
the assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) to generate an atlas of
accessible and modified chromatin sites.
Initially, chromatin conformation was probed at
locations corresponding to the 1,000 highest score peaks
from 2-DPT NEUROG2 ChIP-seq datasets. Enrichment
at these sites was evaluated using ATAC-seq datasets
collected from MRC-5, NEUROG2-transduced MRC-5, and
NFD-treated MRC-5. The majority of these binding events
occurred in the absence of ATAC-seq signal, indicating
that NEUROG2 functions effectively as a pioneer factor
to access closed chromatin (Figure 2A). While only a
modest increase in open chromatin is detected upon
NEUROG2 expression, FD significantly enhances acces-
sible chromatin at NEUROG2 binding sites and other
pro-neural genetic regulatory elements. For instance,
NEUROG2 binds within closed chromatin in the INSRR-
NTRK1, LRRC10B-SYT7, and GADD45G loci, but a signifi-
cant increase in relaxed chromatin is observed only in
the presence of FD (Figure 2B). This demonstrates a role
for FD in modulating accessibility at targets relevant to
neuronal reprogramming.
Lineage-determinative transcription factors can bind
within localized regions of chromatin containing high
densities of histone modifications such as H3K27 acet-
ylation, known as super-enhancers, to regulate gene
expression (Hnisz et al., 2013). An analysis of H3K27AC
super-enhancers in NFD-treated fibroblasts identified
454 potential H3K27AC super-enhancers containing a
NEUROG2 bound site, of which 277 NEUROG2 binding
sites were localized to regions with closed chromatin signa-
tures (Figure 2C). While FD promoted an increase in acces-
sibility from 50 to 118 sites, the vast majority of NEUROG2
binding sites in super-enhancers remained localized to re-
gions of transposase-inaccessible chromatin (Figure 2C).
As histone acetylation is generally considered a marker of
active transcription, these dichotomous acetylation and
chromatin accessibility results suggest that these features
might not be easily correlated during the earliest stage of
reprogramming. This also highlights the functional impor-
tance of NEUROG2 pioneer activity as a complement to
FD-induced chromatin remodeling.
An analysis of accessible chromatin sites uniquely de-
tected uponNFD treatment revealed that newly open chro-
matin was primarily localized to intergenic and intronic
regions (Figure 2D). A functional classification of the genes
annotated to these newly detected sites revealed strong
enrichment of differentiation and neurogenesis-related
factors (Figure 2E). A scan for transcription factor motifs
that might respond to FD identified 50.1% of peaks
as containing the NEUROG2-targeted enhancer box
motif, as well as 4,672 peaks and 2,075 peaks containing
cAMP response element (CRE) half-site and high-mobility
group (HMG)-box motifs, respectively (Figure 2E). ThisStem Cell Reports j Vol. 7 j 955–969 j November 8, 2016 957
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Figure 2. NEUROG2 Acts as a Pioneer Transcription Factor and Small Molecules Promote Chromatin Accessibility at Pro-neural
Genetic Elements
(A) Clustered heatmaps representing open chromatin events detected at NEUROG2 binding sites (2-DPT ChIP-seq, leftmost black) in fi-
broblasts (MRC-5, black), NEUROG2-transduced fibroblasts (N, blue), and NFD-treated fibroblasts (NFD, rightmost red). Input-normalized
tag densities are plotted in log2 scale and centered in a 4-kb window around each peak.
(B) NEUROG2 ChIP-seq (2 DPT) and ATAC-seq tracks for INSRR/NTRK1, LRRC10B/SYT7, and GADD45G genomic loci. Gray shading highlights
regions of NEUROG2 pioneer activity or FD-induced chromatin remodeling.
(C) Super-enhancers identified using H3K27AC and 2-DPT NEUROG2 ChIP-seq datasets with a Venn diagram depicting the distribution of
super-enhancers in open versus closed chromatin.
(D) Genomic distribution of ATAC-seq peaks newly detected upon NFD treatment is biased toward intergenic and intronic genetic elements.
(E) Gene ontology analysis of open chromatin peaks newly detected following NFD treatment reveals an enrichment of neurogenesis- and
differentiation-related classifications. Additionally the enhancer box, CRE half-site, and HMG-box motifs are diversely represented within
these sites.
(F) Pairwise scatter plot representing the change in expression of genes annotated to ATAC-seq open chromatin peaks newly detected upon
NFD treatment. Upregulated genes (red) were enriched for pro-neuronal identity, while downregulated genes (blue) had primarily non-
neural function. Black dots indicate genes without significant changes.motif-based approach hints that FD might improve the
accessibility of genetic regulatory elements via activation
of other transcription factors critical to reprogramming.
A pairwise analysis of RNA-seq datasets was performed
for genes annotated to ATAC-seq peaks uniquely detected
in the NFD condition to identify how changes in chro-
matin structure affect gene expression (Figure 2F). This
integrated analysis identified pro-neural genes involved
in neurogenic transcription, Notch and Wnt signaling,958 Stem Cell Reports j Vol. 7 j 955–969 j November 8, 2016and chromatin remodeling. Collectively, these datasets
demonstrate that NEUROG2 functions as a pioneer tran-
scription factor, while FD promote chromatin remodeling
at pro-neural genes upregulated during reprogramming.
PRKACA Can Phosphorylate NEUROG2 Heterodimers
to Modify DNA Affinity
Forskolin is a well-established activator of cAMP synthesis
and PRKACA (protein kinase cAMP-activated catalytic
subunit a) kinase activity. To demonstrate that increased
intracellular cAMP is fundamental to reprogramming, we
successfully replaced forskolin with cAMP or dibutyryl
cAMP during reprogramming (Figure S3A). Increased intra-
cellular cAMP catalyzes the release of PRKACA from its reg-
ulatory subunit and stimulates protein kinase A activity.
Remarkably, fibroblasts co-transduced with NEUROG2
and PRKACA rapidly outgrow TUBB3+ and MAP2+ neurites
within 12 days (Figure S3B).
From these findings, we hypothesized four mechanisms
by which FD might enhance NEUROG2 binding and
promote chromatin remodeling (Figure 3A). The simplest
mechanism is an FD-induced post-translational phosphor-
ylation event that modulates NEUROG2 function. Cyclin-
dependent kinases and glycogen synthase kinase 3 have
been shown to regulate NEUROG2 DNA affinity, neuron
differentiation, and motor neuron specification through
site-specific phosphorylation (Ali et al., 2011; Ma et al.,
2008). To identify whether increased NEUROG2 phosphor-
ylation by PRKACA or another kinase is a primary function
of FD during reprogramming, we performed introduced
phosphodeficient and phosphomimetic amino acids at
serine residues with a high probability for phosphoryla-
tion. Surprisingly, the replacement of S24, S91, S193,
S207, S209, S219, S232, S239, or S242 had no effect on re-
programming efficiency, speed of conversion, or neuron
morphology (Figures S3C and S3D). Even a NEUROG2
construct carrying substitutions at seven of these residues
exhibited no effect on reprogramming. Although not an
exhaustive analysis, this screen suggests that FD might
act via another mechanism to drive the changes observed
in ChIP-seq and ATAC-seq datasets.
To evaluate the second hypothetical mechanism un-
derlying enhanced NEUROG2 chromatin occupancy, we
investigated whether FD promote the phosphorylation of
heterodimeric NEUROG2 complexes to enhance chro-
matin affinity. NEUROG2 heterodimers have been shown
to exhibit variable chromatin affinity and functional
stability in developing and mature neurons (Bronicki
et al., 2012; Li et al., 2012). As a proof of principle, fibro-
blasts transduced with a minimal NEUROG2 construct
(NEUROG2110–228) containing only the DNA binding
domain and a single transactivation domain exhibited sig-
nificant deficits in reprogramming efficiency (Figure S3E).
Importantly, this minimal structure did not entirely
abolish the generation of neuron-like MAP2+ cells, indi-
cating that NEUROG2110–228 is a functional but inefficient
transcriptional activator. Next,mass spectrometrywas used
to identify NEUROG2 co-factors (Figure S3F). This revealed
direct interactionwith transcription factor 3 (TCF3), which
has been shown to modulate NEUROG2 chromatin bind-
ing dynamics in a phosphorylation-dependent manner
(Li et al., 2012).To investigate whether PRKACA phosphorylates TCF3
and related co-factors that heterodimerize with NEUROG2,
we co-expressed PRKACA with TCF3 isoform E12, TCF3
isoform E47, TCF4, and TCF12. A denaturing electropho-
retic analysis revealed that TCF3, TCF4, and TCF12 are
phosphorylated by PRKACA (Figure S3G). Next, we as-
sessed the functional roles for this phosphorylation.
Genomic sequences extracted from NEUROG2 ChIP-
seq occupancy sites annotated to the 100most upregulated
and downregulated genes identified by RNA-seq were
directionally searched to identify the distribution of
enhancer box sequences at these sites (Figure S4A). Three
unique sequences, 50-CAGCTG-30, 50-CAGATG-30, and
50-CATCTG-30, were strongly enriched within this subset
of binding sites. Phosphorylation-dependent binding of
NEUROG2 heterodimers to each of these enhancer box
sequences was assayed using microscale thermophoresis
(Figures S4B–S4D) (Wienken et al., 2010).
DNA binding-induced changes in the thermophoresis of
recombinant GFP-labeled NEUROG2 enabled us to quanti-
tatively define the effects of differential phosphorylation
on heterodimer affinity for sequence-specific enhancer
box motifs. A preliminary electrophoretic mobility shift
assay demonstrated that NEUROG2 homodimers do not
bind DNA (Bronicki et al., 2012), GFP fusion does not
affect NEUROG2 association with TCF3, and NEUROG2
efficiently binds a ChIP-identified DLL3 enhancer box
in vitro (Figure S4E). Thermophoretic traces were collected
using differentially phosphorylated NEUROG2-TCF3 het-
erodimers and a DLL3 50-CAGCTG-30 native enhancer
box or mutagenized internal dinucleotide pair to encode
50-CAGATG-30 and 50-CATCTG-30. Surprisingly, phosphor-
ylation caused sequence-specific reductions in enhancer
box affinity (Figures S4B–S4D). Among several possibilities,
this result suggests that TCF3 phosphorylation might be a
mechanism for enhancing the specificity and resolution
of NEUROG2 binding in a sequence-dependent manner,
but is not likely to be the primary mechanism underlying
enhanced chromatin accessibility or occupancy.
CREB1 Promotes Neuron Survival
In contrast to direct post-translational modifications, FD
might mediate synergistic changes in gene expression
and chromatin remodeling through PRKACA-targeted
transcription factors that complement the NEUROG2 tran-
scription program. To investigate our third proposedmech-
anism, we performed sequence-based discovery of regulons
using RNA-seq datasets for upregulated genes without
NEUROG2 annotation (Janky et al., 2014). This enabled
the identification of 79 FD-induced genes containing at
least one CRE motif within 5 kb of the target TSS (Table
S2). CRE binding protein 1 (CREB1) directly interacts
with this enriched motif and is an established target ofStem Cell Reports j Vol. 7 j 955–969 j November 8, 2016 959
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Figure 3. Small Molecules Activate CREB1 to Promote Neuron Survival and SOX4 Upregulation
(A) Four hypothetical mechanisms that might underlie NEUROG2 and FD synergy.
(B) Immunoblot of shRNA-mediated CREB1 knockdown.
(C) CREB1 knockdown significantly reduces the viability of reprogrammed neurons (mean ± SD; n = 10 random image fields from biological
triplicates). Relative survival represents (GFP+ and Hoechst 33342+ cells at each time point)/(total GFP+ and Hoechst 33342+ cells
at 1 DPT).
(D) Phospho-CREB1 (pS133) ChIP-qPCR at CREB1 targets (NR4A1, SIK1), NEUROG2 targets with FD-enhanced expression (GADD45G, SOX4),
and controls (NEUROG2 target, DLL3; within gene, NR4A1 open reading frame) for NEUROG2-transduced fibroblasts (blue) and NFD-treated
fibroblasts (red) at 1 DPT (mean ± SD; biological triplicates).
(E) NEUROG2 occupancy around the SOX4 locus. NEUROG2 occupancy is represented as an overlay of 0.5-DPT (light), 1-DPT (medium), and
2 DPT (dark) NEUROG2 ChIP-seq traces from NEUROG2-transduced fibroblasts (blue) and NFD-treated fibroblasts (red). Purple hashes
indicate CRE motif sequences.
(F) Condition-dependent SOX4 expression from RNA-seq results at 2 DPT (mean values from biological triplicate RNA-seq data).
(G) NEUROG2 and CREB1 ChIP from control and NFD-treated fibroblasts reveals chromatin co-occupancy in NFD-treated fibroblasts.PRKACA phosphorylation (Gonzalez and Montminy,
1989). To investigate whether FD-activated CREB1 is essen-
tial to reprogramming, we performed CREB1 knockdown960 Stem Cell Reports j Vol. 7 j 955–969 j November 8, 2016using a small hairpin RNA (shRNA) co-expressed with
NEUROG2 (Figure 3B). CREB1 knockdown significantly
reduced the survival of NFD-treated fibroblasts, indicating
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Figure 4. SOX4 Promotes Open Chromatin
Patterns during Reprogramming
(A) Immunoblot validation of shRNA-medi-
ated SOX4 knockdown.
(B) SOX4 knockdown significantly reduces
neuronal conversion (mean ± SD; n = 10
random image fields from biological trip-
licates). Reprogramming efficiency repre-
sents (GFP+ and MAP2+ cells)/(total GFP+
cells).
(C) Area-proportional Venn diagram de-
picting the total number of SOX4 binding
events and the proportion shared with
NEUROG2. The adjacent pie diagram repre-
sents the relative fold increase in normal-
ized transcript number for co-bound genes
in NEUROG2-transduced fibroblasts in the
presence versus absence of FD from RNA-seq
datasets.
(D) NEUROG2 ChIP-seq track (2 DPT) and
ATAC-seq tracks generated from fibroblasts
(MRC-5), NEUROG2-transduced fibroblasts
(N), NFD-treated fibroblasts (NFD), and
NFD-treated fibroblasts co-expressing SOX4
shRNA (NFD + SOX4 shRNA) around the
NEUROD1 and NEUROD4 loci. Gray shading highlights representative regions of FD-enhanced chromatin accessibility lost upon SOX4
knockdown.
(E) Area-proportional Venn diagram depicting the total number of ATAC-seq events in NFD-treated fibroblasts relative to the number of
events detected at the same locations upon SOX4 knockdown. The adjacent pie diagram represents the relative peak score change for
shared sites (NFD peak score)/(NFD + SOX4 shRNA peak score).
(F) NEUROD1 and NEUROD4 ChIP-qPCR at sites of newly open chromatin or NFD-induced genes (mean ± SD; biological triplicates).that CREB1 is critical to induced neuron survival (Fig-
ure 3C). This survival effect during reprogramming is
consistent with its known role in endogenous neurons
(Finkbeiner, 2000).
Next, an antibody specific for PRKACA-mediated CREB1
phosphorylation was used to perform ChIP-qPCR (Fig-
ure 3D). ChIP specificity was validated using established
target genes (NR4A1 and SIK1), which both exhibited
significant FD-induced upregulation in RNA-seq datasets.
Interestingly, FD-enhanced phospho-CREB1 binding at
SOX4 compared with binding in the absence of FD (Fig-
ure 3D). A genomic search revealed that several consensus
CRE sites are located adjacent to NEUROG2 occupancy
sites in the SOX4 enhancer (Figure 3E). Supporting a coop-
erative role for active CREB1 and NEUROG2 in SOX4 regu-
lation, upregulation of SOX4 by FD could be further
enhanced by NEUROG2 (Figure 3F). To evaluate whether
co-binding might occur at numerous locations, we per-
formed co-immunoprecipitation (coIP) on NEUROG2 and
CREB1 chromatin (Figure 3G). NEUROG2-bound chro-
matin exposed positive for CREB1 and CREB1-bound
chromatin validated this result, with NEUROG2 detected
in NFD-treated cells but not control cells. These resultsdemonstrate that FD enhances CREB1 enrichment at
chromatin locations co-bound by NEUROG2.
SOX4 Promotes Chromatin Remodeling during Early
Reprogramming
SOX4 is an HMG transcription factor with roles in pan-
neuronal gene expression networks and the maturation
of differentiating neurons (Bergsland et al., 2006; Shim
et al., 2012). To investigate whether SOX4 upregulation is
critical during early reprogramming, we performed SOX4
knockdown inNFD-treated fibroblasts (Figure 4A). Remark-
ably, disrupted SOX4 expression resulted in morphological
defects and nearly abolished reprogramming (Figure 4B).
ChIP-seq was next used to define the genetic targets of
this factor. Alignment of SOX4 and NEUROG2 profiles re-
vealed significant overlap with 413 of 1,119 total SOX4
binding events directly shared with NEUROG2 (Figure 4C).
Peak-to-gene annotation next enabled an analysis of how
co-binding effects gene expression. Relative to NEUROG2
alone, NFD-treated cells exhibited enhanced transcription
for 81% of co-bound genes including NEUROD1 and
NEUROD4 (Figure 4C). In addition, these datasets demon-
strated that SOX4 also targets components of the SWI/SNFStem Cell Reports j Vol. 7 j 955–969 j November 8, 2016 961
nucleosome remodeling complex including ARID1A,
ARID1B, SMARCA2, SMARCAD1, SMARCC1, SMARCC2,
SMARCD1, SMARCD2, and SMARCE1 (Kwon et al., 1994;
Son and Crabtree, 2014). This suggests that SOX4 not
only functions to regulate transcription via direct chro-
matin binding but might indirectly promote chromatin
remodeling to increase accessibility.
A comprehensive analysis of this indirect chromatin re-
modeling activity was performed using SOX4 knockdown
coupled with ATAC-seq in NFD-treated fibroblasts. FD-
induced chromatin decondensation at NEUROG2 binding
sites and adjacent genetic elements in the NEUROD1 and
NEUROD4 loci is significantly reduced following SOX4
depletion (Figure 4D). As both of these genes are signifi-
cantly upregulated only in theNFD condition, this analysis
demonstrates how the synergistic co-binding of NEUROG2
and SOX4 accompanied by a transition to open chromatin
patterns is fundamental to the expression of genes that
promote reprogramming. Broadening this to a genome-
wide analysis, SOX4 knockdown results in an extensive
loss of approximately 59% of total open chromatin sites
in NFD-treated fibroblasts (Figure 4E). A simultaneous
decrease in ATAC score is also observed for 22% of the
remaining peaks following knockdown.
NEUROD1 is required to promote human fibroblast-to-
neuron reprogramming (Pang et al., 2011). As they repre-
sent direct downstream targets of NEUROG2 and SOX4,
ChIP for NEUROD1 and NEUROD4was used to investigate
the occupancy of these factors within regions of newly
open chromatin (Figure 4F). Publicly available ChIP-seq da-
tasets from mouse cortical tissue were analyzed for poten-
tial target sites that directly overlapwith humanNEUROG2
ChIP and ATAC-seq sites (Pataskar et al., 2016). NEUROD1
was enriched at NEUROG2 bound sites in regions of DLL3,
HES6, and NHLH1, while NEUROD4 was significantly
less enriched within these loci in reprogrammed human
fibroblasts. Furthermore, NEUROD1 exhibited modest
enrichment at the NEUROD4 promoter within an open
chromatin site lost following SOX4 depletion. These find-
ings collectively implicate FD-induced upregulation of
SOX4 in pro-neural chromatin remodeling activity.
NEUROG2 and SOX4 Induce H3K27 Acetylation at
Pro-neural Genetic Elements
We next performed a condition-dependent analysis of
H3K27AC and H3K27 trimethylation (H3K27ME3) to
define the native epigenetic landscape of fibroblasts and
factor-specific changes triggered during reprogramming.
First, a quantitative analysis of H3K27AC ChIP-seq read
densities around NEUROG2 ChIP-seq peaks revealed that
FD only modestly enhanced acetylation at these sites. In
contrast, FD significantly enhanced H3K27AC enrichment
surrounding SOX4-targeted genomic sites (Figure 5A). Sec-962 Stem Cell Reports j Vol. 7 j 955–969 j November 8, 2016ond, this FD-enhanced acetylation is even more pro-
nounced at occupancy sites annotated to genes targeted
by both NEUROG2 and SOX4 (Figure 5B). This further
demonstrates that the synergistic genetic and epigenetic
reprogramming induced by NEUROG2 and FD is, at least
in part, mediated by SOX4.
In-depth analysis of transcription factor binding profiles
and histone marks at DLL3 and SMARCC2 provided in-
sights into both the mechanism of reprogramming and
the epigenetic environment of MRC-5 fibroblasts. For
instance, binding sites for NEUROG2 and SOX4 directly
overlap upstream of DLL3, and H3K27AC enrichment
significantly increases at this site upon FD treatment (Fig-
ure 5C). A simultaneous loss of H3K27ME3 is observed
throughout this region. In contrast, the SWI/SNF subunit
SMARCC2 is targeted only by SOX4, and the H3K27ME3
signal is relatively low throughout this locus (Figure 5D).
This indicates that MRC-5 fibroblasts might be more epige-
netically poised for reprogramming than other lineage-
committed adult skin fibroblasts.
Induced Neuronal Identity in Cell Types Refractory to
NEUROG2 Reprogramming
The success of neuronal reprogramming depends upon
the ability of exogenous reprogramming factors and down-
stream induced transcription factors to traverse the cell-of-
origin epigenetic environment. Unlike the high-efficiency
conversion of fetal MRC-5 fibroblasts, NEUROG2 and FD
do not functionally or morphologically reprogram adult
skin fibroblast lines without additional SOX11 overexpres-
sion (Liu et al., 2013). Likewise, the addition of FGF2 and
kenpaullone to this reprogramming cocktail promote the
survival of reprogrammed neurons (Liu et al., 2013,
2015). As SOX4 and SOX11 exhibit redundant functions
in the developing nervous system (Cheung et al., 2000;
Miller et al., 2013), we investigated whether an inability
to activate this factor hinders adult cell reprogramming
efficiency.
An initial assessment of SOX4 expression in adult
skin fibroblast lines revealed that adult fibroblasts express
SOX4 at comparatively lower levels than MRC-5 (Fig-
ure 6A). Next, we evaluated whether SOX4 upregulation
is beneficial to reprogramming by transducing adult fibro-
blasts with NEUROG2- and SOX4-encoding lentivirus in
combination with FD and FGF2. These factors induced
TUBB3 expression and modest neurite outgrowth in all
four lines (Figure 6B). However, the progressive maturation
of these neurons is significantly slower and less complex
than neurons derived from fetal cells (Figure 6C).
A SOX4 ChIP time course using AG05811 adult fibro-
blasts provided insight into the varied genetic landscapes
of adult and fetal fibroblast lines. SOX4 enrichment at sites
identified by ChIP-seq in 1-DPT MRC-5 cells exhibited
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Figure 5. Small Molecules Enhance H3K27 Acetylation at NEUROG2- and SOX4-Targeted Genetic Elements
(A and B) Distribution of H3K27 acetylation (H3K27AC) ChIP-seq reads from untreated fibroblasts (black), NEUROG2-transduced fibroblasts
(blue), and NFD-treated fibroblasts (red) centered around (A) SOX4 ChIP-seq peaks and (B) NEUROG2 and SOX4 co-bound peaks within a
4-kb window.
(C and D) ChIP-seq tracks for SOX4, NEUROG2, H3K27 acetylation, and H3K27 trimethylation generated from fibroblasts (MRC-5), NEUROG2-
transduced fibroblasts (N), and NFD-treated fibroblasts (NFD) around the (C) DLL3 and (D) SMARCC2 loci.significantly delayed occupancy in adult cells through 4
DPT (Figure 6D). This suggests that condensed chromatin
might occlude the binding sites of SOX4 and other down-
stream NEUROG2-driven transcription factors to inhibit
the neurogenic transcription programs critical to adult
fibroblast reprogramming.
Under conditions of chromatin accessibility, NEUROG2,
FD, and the endogenous upregulation of SOX4 should be
sufficient to drive reprogramming of adult fibroblasts.
Since SOX4 targets numerous subunits of the SWI/SNF
complex (Figure 4C), SMARCA4 and NEUROG2 were co-ex-
pressed to determine whether chromatin remodeling could
potentiate reprogramming (Figure 6E). A fraction of trans-
duced fibroblasts rounded, outgrew neurites, and exhibited
modest TUBB3 expression but, similar to SOX4 overex-
pression, these fibroblasts did not adopt highly complex
neuronal morphology. The co-expression of SMARCB1
and SMARCC2 with NEUROG2 and SMARCA4 failed to
further improve conversion.A chemical screen targeting chromatin modifiers was
then performed to identify whether compounds that
enhance chromatin accessibility could improve adult fibro-
blast reprogramming (Figure 6E). We identified several
chemicals sufficient to induce rounding and modest neu-
rite outgrowth, but only the histone deacetylase inhibitor
FK228 was sufficient to rapidly induce a large cell popula-
tionwith neuron-likemorphology (Figure 6F). Remarkably,
thismorphological conversion occurredwithin 20–24 hr of
exposure; however, cells treated with 0.5 mM FK228 failed
to survive long term in culture.
In addition to histone deacetylase inhibition, FK228 sup-
presses the RAS-MAP kinase signaling pathway to induce
apoptosis (Kobayashi et al., 2006). To abrogate these pro-
apoptotic functions while retaining histone deacetylase
inhibition, we pre-treated adult skin fibroblasts with the
pan-caspase inhibitor Z-VAD-FMK (Wang et al., 2012), the
necrosis inhibitor necrosulfonamide, and the ferroptosis
inhibitor liproxstatin-1. Fibroblasts were continuouslyStem Cell Reports j Vol. 7 j 955–969 j November 8, 2016 963
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Figure 6. Increased Chromatin Accessibility Promotes Human Adult Fibroblast and Glioblastoma Cell Reprogramming
(A) Expression of SOX4 RNA and protein in adult fibroblast lines relative to fetal MRC-5 fibroblasts (mean ± SD; biological quadruple
samples for qPCR).
(B) Percentage of rounded adult fibroblasts expressing TUBB3 when treated with NFD, FGF2, and mouse Sox4 (red) or human SOX4 (gray)
(mean ± SD; n = 10 random image fields from biological triplicates).
(C) Examples of progressive neuronal conversion using adult fibroblasts treated with reprogramming factors. Fibroblasts adopt a rounded
morphology (5–10 DPT), outgrow low-complexity neurites (10–20 DPT), and infrequently adopt complex neuronal morphology (R21 DPT).
Scale bars, 20 mm.
(D) SOX4 ChIP-qPCR time course demonstrating SOX4 chromatin occupancy at 1, 2, and 4 DPT in adult fibroblasts treated with re-
programming factors (mean ± SD; biological triplicates for each ChIP).
(legend continued on next page)
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treated starting at 1 day before FK228 treatment and 2 days
following FK228 exposure. Due to the rapid adoption of
neuronal morphology, we also included the brain-derived
neurotrophic factor BDNF, the glial cell line-derived neuro-
trophic factor GDNF, and neurotrophin-3 at the outset of
reprogramming. Fibroblasts treated with FK228 for 24 hr
starting 2 days after infection exhibited modest improve-
ments in cell survival upon Z-VAD-FMK treatment. Liprox-
statin-1 and necrosulfonamide exhibited no effect on
cell survival or reprogramming efficiency. While Z-VAD-
FMK increased the survival of induced neurons compared
with FK228 alone, a significant fraction of cells still died
5–7 days after initial transduction.
FK228-induced apoptosis is highly sensitive to BCL2L1
activity, but remains unaffected by BCL2 (Newbold et al.,
2008). We then co-expressed BCL2L1 with NEUROG2
to determine whether cell survival could be enhanced
following FK228 treatment. Interestingly, adult fibroblasts
co-expressing NEUROG2 and BCL2L1 for 4 days in neuron
induction medium followed by a brief 24-hr exposure to
FK228 from days 4–5 generated morphologically complex
neurons that stained TUBB3+, MAP2+, and RBFOX3+ after
12 days in culture (Figures 6G and 6H). These results
show the neuronal reprogramming capacity of FK228
when apoptotic mechanisms are controlled during conver-
sion. This chemical-based approach to chromatin modifi-
cation further demonstrates that NEUROG2 and small
molecules are sufficient to induce early neurogenic pro-
grams in fibroblasts refractory to reprogramming in the
absence of epigenetic barriers to activity. The toxicity of
FK228 to fibroblasts not transduced with BCL2L1 resulted
in fluorescent cell debris that occluded an extensive immu-
nochemical analysis of neuronal maturation. Further opti-
mization is needed for long-term survival, maturation, and
subtype identity analyses.
Distinct cell types exhibit disparate heterochromatin
condensation patterns. To investigate whether a more
permissive chromatin statewould facilitate rapid reprogram-
ming, we reprogrammed adult human U-251 glioblastoma
cells. In the absence of SOX4 overexpression, NFD-treated(E) Screen for chromatin-modifying chemicals and SWI/SNF factors t
() of morphological change, soma rounding, neurite outgrowth, an
(F) Exposure to FK228 for 20–24 hr induces rapid neuron-like morpholo
converted cells at the bottom left are still undergoing morphological
(G) BCL2L1 significantly enhances the survival of FK228 treated ce
expression of neuronal markers such as TUBB3, MAP2, and RBFOX3. S
(H) Percentage of adult AG05811 fibroblasts overexpressing NEUROG2
time point represents FK228 exposure during the 24-hr window from 2
n = 10 random image fields from biological triplicates for two virus c
(I) Percentage of reprogrammed U-251 glioblastoma cells expressing
SOX4. MAP2 and TUBB3 immunocytochemical staining of neurons gen
biological triplicates for each experiment). Scale bar, 50 mm.cells adopt TUBB3+, and MAP2+ neuron-like morphology
with 21% ± 3% efficiency (Figure 6I). However, inclusion
of SOX4 endows these cells with complex morphology and
conversion efficiency of greater than 90% (Figure 6I). This
alternative cellular context provides independent confirma-
tionof the fundamental roles playedbySOX4and SOX4-tar-
geted downstream actors in neuronal reprogramming.
Collectively, these findings represent a stepwise molecu-
lar mechanism for the synergistic events underlying early
fibroblast-to-neuron reprogramming (Figure 7). The hier-
archical activation of NEUROG2, CREB1, and SOX4
transcriptional programs, as well as, FD-induced chromatin
remodeling, can potentiate reprogramming in a cell
age- and lineage-dependent manner.DISCUSSION
Here we performed genome-wide ATAC-seq, ChIP-seq, and
RNA-seq profiling to define the immediate-early molecular
events that catalyze fibroblast-to-neuron reprogramming
by NEUROG2 and small molecules. While NEUROG2 is
sufficient to reprogram glial cells into neurons, this tran-
scription factor fails to reprogram somatic fibroblasts
independent of the small molecules F and D (Liu et al.,
2013). This synergistic reprogramming activity is the result
of extensive SOX4-mediated chromatin remodeling that
enhances NEUROG2 occupancy at pro-neural genetic ele-
ments and, in coordination with downstream factors, rede-
fines the fibroblast transcriptome. These findings enabled
us to reprogram adult fibroblasts and glioblastoma cells
refractory to conversion by NEUROG2 alone.NEUROG2 Functions as a Pioneer Factor during Early
Reprogramming
Transcription factors in both pluripotent and direct reprog-
ramming systems utilize either off-target cooperative
chromatin binding (Soufi et al., 2012) or on-target
pioneer binding mechanisms to activate gene expression
(Wapinski et al., 2013). Similar to ASCL1 function inhat promote neuronal reprogramming. The presence (+) or absence
d TUBB3 expression at 8 DPT was evaluated.
gy. Arrows indicate cells with advanced morphology, while partially
restructuring.
lls, enables the adoption of complex morphology, and promotes
cale bars, 50 mm.
and BCL2L1 that reprogram into TUBB3+ neurons at 10 DPT. Each
–3, 3–4, or 4–5 days after initial lentiviral transduction (mean ± SD;
onditions at each time point).
TUBB3 (red) and MAP2 (gray) when treated with NFD or NFD with
erated at 10 DPT (mean ± SD; n > 10 independent experiments with
Stem Cell Reports j Vol. 7 j 955–969 j November 8, 2016 965
CREB1 E Protein NEUROG2
HO
OH
O
O
O
O
OH
SOX4 E Protein NEUROG2
Figure 7. Simplified Molecular Mecha-
nisms Underlying Fibroblast-to-Neuron
Reprogramming
NEUROG2, a pioneer transcription factor,
targets thousands of pro-neural genetic
elements. Small molecules simultaneously
activate signaling cascades that promote
NEUROG2 and CREB1 co-transcription, induce
SOX4 expression, enhance H3K27 acetyla-
tion, and promote SOX4-dependent chro-
matin remodeling. NEUROG2 and SOX4 syn-
ergize to enhance the expression of diverse
pro-neural transcription factors and drive
neuron identity in diverse fibroblast and
glioblastoma cell types.mouse embryonic fibroblasts, NEUROG2 exhibits on-
target pioneer binding in heterochromatin regions when
expressed in human fetus. Unexpectedly, however, FD-
induced chromatin remodeling dramatically enhances
NEUROG2 chromatin occupancy.
This enhanced occupancy demonstrates that FD act syn-
ergistically with NEUROG2 to promote reprogramming
rather than function as complementary, but independent
transcriptional activators. We investigated four mecha-
nisms by which FD might enhance NEUROG2 activity in
a cell lineage-dependent manner. This revealed that FD
enhance chromatin accessibility to promote hierarchical
associations with CREB1 and SOX4 to initiate secondary
pro-neural transcription programs. These observations
validated an earlier computational model indicating that
CREB1 acts as a co-activator of NEUROG2 during mouse
telencephalon development (Gohlke et al., 2008), as well
as roles for SOX4 in establishing a cross-regulatory neuro-
genic network involving SWI/SNF complex factors (Nin-
kovic et al., 2013). The genome-wide interplay of CREB1,
NEUROG2, and SOX4 during reprogramming highlights
how tightly interwoven genetic regulatory networks
require coordinated multi-factor occupancy to effec-
tively enhance the expression of pro-neural downstream
actors previously implicated in reprogramming such as966 Stem Cell Reports j Vol. 7 j 955–969 j November 8, 2016NEUROD1 (Pang et al., 2011, Guo et al., 2014) and
NEUROD4 (Masserdotti et al., 2015).
SOX4 Indirectly Enhances Neuronal Identity through
Chromatin Remodeling
Sox4 and Sox11 exhibit similar expression patterns in the
developing nervous system, and simultaneous, but not
independent, knockout of these factors results in reduced
neuron survival (Cheung et al., 2000; Miller et al., 2013).
CHD7 activates a neuronal differentiation program in neu-
ral stem cells by remodeling the Sox4 and Sox11 promoters
to upregulate expression (Feng et al., 2013). Of these tran-
scription factors, only SOX4 is significantly expressed in
human MRC-5 fibroblasts, and transient knockdown of
SOX4 abolishes reprogramming. Importantly, NEUROG2
outcompetes REST to drive Sox4 and promote neuronal
differentiation in post-mitotic neural precursor cells
(Bergsland et al., 2006). In parallel with this mechanism,
NEUROG2 co-binds with CREB1 to upregulate SOX4 in
MRC-5 fibroblasts, demonstrating similar regulatorymech-
anisms during development and reprogramming.
An analysis of SOX4 targets revealed extensive coor-
dination with NEUROG2 at factors with FD-enhanced
or synergistically induced expression such as HES6,
NEUROD1, NEUROD4, and WNT10A. In addition to
synergistic regulation, SOX4 targets epigenetic remodeling
factors such as EZH2 (Tiwari et al., 2013) and numerous
SWI/SNF subunits.
In parallel with this epigenetic function, the inclusion of
either SOX4 or SOX11 is required to induce adult fibro-
blasts and glioblastoma cells to adopt TUBB3+ identity
(Liu et al., 2013; Su et al., 2014). The morphological
complexity of these neurons can be significantly enhanced
with ISL1 and LHX3 overexpression (Liu et al., 2015). As
adult fibroblast lineages exhibit highly defined epigenetic
signatures that make these cells less poised for reprogram-
ming, mechanistic studies have predominantly relied on
embryonic or fetal fibroblasts (Masserdotti et al., 2015;Wa-
pinski et al., 2013; Gasco´n et al., 2016). Our proposed
mechanism suggests that SOX4 reduces epigenetic barriers
to reprogramming to facilitate fate conversion of adult cell
lineages.
Maturemammalian neurons exhibit distinct epigenomic
signatures that reflect subtype-specific functions. Based on
our ATAC-seq and SOX4 ChIP-seq datasets, we hypothe-
sized that modulating the epigenome of fibroblasts with
chromatin remodeling complexes might enhance reprog-
ramming efficiency as observed with induced pluripotent
stem cells (Singhal et al., 2010). While a subset of adult fi-
broblasts transduced with both SMARCA4 and NEUROG2
expressed TUBB3 and low-complexity neurites, the addi-
tion of other SWI/SNF subunits such as SMARCB1 and
SMARCC2 failed to improve reprogramming, likely due to
imbalances in subunit stoichiometric required for a mini-
mally functional SWI/SNF complex.
Targeting Epigenetic Modifiers Enhances Adult
Human Fibroblast Reprogramming
We next turned to a small-molecule-based strategy
for epigenetic remodeling inspired by recently described
chemical reprogramming systems (Hu et al., 2015; Li
et al., 2015; Zhang et al., 2015). This led to the replace-
ment of SOX4 by FK228, which rapidly induces neuron
morphology but confers poor survival. Upon co-expression
of NEUROG2 and BCL2L1 with FK228 we observed
morphologically complex neurons. While we were not
able to directly image MAP-tau expression due to high
background, these cells did become TUBB3+, MAP2+, and
RBFOX3+. Collectively, these results highlight multiple
roles for SOX4 in early reprogramming as well as the func-
tional impact of epigenetic remodeling on reprogramming
efficiency in adult cells.
Chromatin Accessibility and Histone Signatures
Regulate Reprogramming Efficiency
Distinct histone acetylation and methylation signatures
regulate transcription factor activity and gene expression.
Patterned post-translational modifications direct transcrip-tion factors to specific genomic regulatory regions.
H3K27AC enrichment was observed at both NEUROG2
and SOX4 bound sites in reprogrammed fibroblasts.
Furthermore, FD significantly increased this enrichment
at cooperatively bound sites.
CREB1 phosphorylation promotes the recruitment of
histone acetyltransferases that induce local nucleosome
remodeling (Michael et al., 2000). This activity likely medi-
ates, in part, the FD-enhanced acetylation observed at
NEUROG2 occupancy sites. Histone acetyltransferase in-
hibitors such as valproic acid (Niu et al., 2013) and FK228
drive the adoption of neuronal identity, underscoring
the significance of persistent acetylation at neurogenic
promoters during early conversion.
Collectively, this work presents a stepwise mechanism
detailing the early events critical to fibroblast-to-neuron re-
programming and highlights how changes to the cell-of-
origin chromatin landscape measurably affect conversion
efficiency.EXPERIMENTAL PROCEDURES
ATAC-Seq
Fluorescent-sorted cells were lysed, resuspended in transposition
mix, incubated for 30 min at 37C, and amplified with barcoded
primers. Single-end 50-base length reads were generated and
aligned to GRCh37/hg19 for analysis.
ChIP, ChIP CoIP, and ChIP-Seq
ChIP and ChIP-seq used fibroblasts transduced withHA-NEUROG2
orNEUROG2+HA-SOX4. Cells were fixed and lysed, and nuclei sus-
pended in shearing buffer. Chromatinwas sheared, quantified, and
combinedwith target-specific antibodies. Chromatinwas captured
with magnetic beads, washed, eluted, and reverse crosslinked.
Single-end 50-base length reads were generated and aligned to
GRCh37/hg19 for analysis. ChIP coIP followed the same protocol
using denaturing buffer elution. Detailed protocols are provided in
Supplemental Experimental Procedures and Table S3.
Neuron Induction
MRC-5 fibroblasts were seeded on standard 24-well glass coverslips,
transducedwithNEUROG2-encoding lentivirus, and supplemented
with 10 mM forskolin and 1 mMdorsomorphin 48 hr after infection.
Medium was changed every 2 days for the duration of culture.
RNA-Seq
Total RNA was isolated from control or treated MRC-5 fibroblasts
and quantified for library synthesis. Single-end 50-base length
sequencing reads were aligned to GRCh37/hg19 for differential
expression analysis.
shRNA-Mediated Gene Knockdown
PCR was used to generate a lentiviral construct containing miR30
regulatory sequences and shRNAs (Table S3; Fellmann et al., 2013).Stem Cell Reports j Vol. 7 j 955–969 j November 8, 2016 967
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